Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Income from Non-Controlling Interests of -$2341.5 for Q1 2026, up 25.8% year-over-year from -$1861.3 in Q1 2025, and up 32.95% quarter-over-quarter from -$3492.1 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Income from Non-Controlling Interests for 7 consecutive years, with -$2341.5 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests rose 25.8% year-over-year to -$2341.5; the TTM figure through Mar 2026 stood at -$8171.7 (up 41.66% YoY), while the FY2025 annual figure was -$9312.3, up 27.38% from the prior year.
- Income from Non-Controlling Interests improved to -$2341.5 in Q1 2026 per STVN's latest filing, from -$3492.1 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $99236.3 in Q2 2022 and bottomed at -$39789.6 in Q4 2022.
- Historically, Income from Non-Controlling Interests has averaged $13603.0 across 5 years, with a median of -$2163.2 in 2024.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 423.99% — and 2024, when it plunged 404.42%.
- Stevanato Group S.p.A's Income from Non-Controlling Interests stood at -$39789.6 in 2022, then soared by 105.41% to $2151.9 in 2023, then plunged by 248.98% to -$3205.8 in 2024, then retreated by 8.93% to -$3492.1 in 2025, then jumped by 32.95% to -$2341.5 in 2026.
- Business Quant data shows STVN's Income from Non-Controlling Interests at -$2341.5 in Q1 2026, -$3492.1 in Q4 2025, and -$2338.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | -3,487.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,487.09 |
| Mar 31, 2026 | -2,341.49 |
| Dec 31, 2025 | -3,492.13 |
| Sep 30, 2025 | -2,338.11 |
| Mar 31, 2025 | -3,155.65 |
| Dec 31, 2024 | -3,205.79 |
| Sep 30, 2024 | -5,491.10 |
| Jun 30, 2024 | -2,153.78 |
| Mar 31, 2024 | -2,172.72 |
| Dec 31, 2023 | 2,151.88 |
| Sep 30, 2023 | -1,088.59 |
| Jun 30, 2023 | 43,556.98 |
| Mar 31, 2023 | 19,320.15 |
| Dec 31, 2022 | -39,789.65 |
| Sep 30, 2022 | 72,595.75 |
| Jun 30, 2022 | 99,236.27 |
| Mar 31, 2022 | 46,015.85 |
| Dec 31, 2021 | -82,365.91 |
| Sep 30, 2021 | -22,406.46 |
| Jun 30, 2021 | 30,106.79 |